Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology(CHESS2207): a Prospective, Multicenter Study

NCT05551884 is registered in ClinicalTrials.gov with Hepatopancreatobiliary Surgery Institute of Gansu Province as lead sponsor.

NCT NCT05551884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05551884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology(CHESS2207): a Prospective, Multicenter Study
Lead sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Phase
Observational
Overall status
Unknown status
Start date
February 15, 2023
Completion date
September 14, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, portal hypertension